Table 1 Prevalence of G6PD deficiency and reference value of G6PD enzyme activity in the study areas
Description | Over all Nay Pyi Taw | Ottara Thiri | Tatkon | Zayar Thiri |
|---|---|---|---|---|
Total samples (males, females) | 772 (579,193) | 332 (299,33) | 160 (80,80) | 280 (200,80) |
Age median (25,75 percentile) | 32 (25,42) | 33 (24,45) | 32 (24,42) | 30 (24,38) |
History of malaria infection (%) | 375/772 (49%) | 190/332 (57%) | 70/160 (44%) | 115/280 (41%) |
G6PD activity value (U/g Hb), SSA | ||||
Adjusted male median (AMM) | 6.3 | 6.6 | 7.8 | 5.8 |
80% of AMM | 5.04 | 5.28 | 6.24 | 4.64 |
70% of AMM | 4.41 | 4.62 | 5.46 | 4.06 |
30% of AMM | 1.89 | 1.98 | 2.34 | 1.74 |
G6PD activity value (U/g Hb), CareStart™ G6PD biosensor | ||||
Adjusted male median (AMM) | 2.58 | 2.58 | ||
80% of AMM | 2.06 | 2.06 | ||
70% of AMM | 1.81 | 1.81 | ||
30% of AMM | 0.77 | 0.77 | ||
Prevalence G6PD deficiency | ||||
Spectrophotometry (< 1.89 U/g Hb) | 10.9% (84/772) | 12.0% (40/332) | 13.1% (21/160) | 8.2% (23/280) |
CareStart™ G6PD RDT | 10.5% (81/772) | 11.7% (39/332) | 11.3% (18/160) | 8.6% (24/280) |
CareStart™ G6PD biosensor (< 0.77 U/gHb) | 12.67% (19/150) | 12.67%(19/150) | ||